Impact of iron/folate versus multi-micronutrient supplementation during pregnancy on birth weight: a randomised controlled trial in rural Western China
| ISRCTN | ISRCTN08850194 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN08850194 |
| Protocol serial number | YH101-H12/03 |
| Sponsor | United Nations Children's Fund (UNICEF) (China) |
| Funder | UNICEF (Project No.: YH101-H12/03) |
- Submission date
- 17/11/2006
- Registration date
- 14/12/2006
- Last edited
- 19/12/2022
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Pregnancy and Childbirth
Plain English summary of protocol
Not provided at time of registration
Contact information
Scientific
No 76 Western Yanta Road
Xi'an
710061
China
| Phone | +86 (0)29 8265 5001 |
|---|---|
| yanhonge@mail.xjtu.edu.cn |
Study information
| Primary study design | Interventional |
|---|---|
| Study design | Grouped randomised double-blind controlled community trial |
| Secondary study design | Randomised controlled trial |
| Study type | Participant information sheet |
| Scientific title | Impact of iron/folate versus multi-micronutrient supplementation during pregnancy on birth weight: a randomised controlled trial in rural Western China |
| Study objectives | 1. The newborn infants of women receiving the multi-micronutrient supplements will at least experience a 50% reduction in prevalence of low birth weight (less than 2500 g) in comparison those receiving folate alone. 2. The newborn infants of women receiving the iron/folate supplements will at least experience a 25% reduction in the prevalence of low birth weight (less than 2500 g) in comparison those receiving folate alone 3. The women receiving the multi-micronutrient supplements in comparison those receiving iron/folate supplements, will at least experience a 30% reduction in the prevalence of anemia (Haemoglobin [Hb] less than 11 g/dL) in the third trimester (30 to 32 weeks of gestation). |
| Ethics approval(s) | Committee for Science and Research at the Xi'an Jiaotong University, 10/04/2002, ref: 2002002 |
| Health condition(s) or problem(s) studied | Low birth weight; preterm delivery; anaemia |
| Intervention | Hamlets were randomly assigned for women to receive one of the following three daily antenatal supplements: 1. Multi-micronutrients 2. Iron and folic acid 3. Folic acid alone (control) The multi-micronutrient supplements were formuated to contain the Required Dietary Allowances (RDA) for each of the micronutrients and if taken throughout pregnancy should provide a sufficient intake of each micronutrient to correct any underlying deficiencies (30 mg iron, 400 µg folate, 15.0 mg zinc, 2.0 mg copper, 65.0 µg selenium, 150.0 µg iodine, 800.0 µg vitamin A, 1.4 mg Vitamin B1, 1.4 mg vitamin B2, 1.9 mg vitamin B6, 2.6 µg vitamin B12, 5.0 µg vitamin D, 70.0 mg vitamin C, 10.0 mg vitamin E, and 18.0 mg Niacin). The iron/folate supplements contained 60 mg of iron and 400 µg of folic acid. The folate-only supplement contained 400 µg of folic acid. These supplements were identical in appearance and participants, investigators, field staff, and statisticians did nor know supplement codes until the study finished. |
| Intervention type | Supplement |
| Primary outcome measure(s) |
1. Duration of pregnancy |
| Key secondary outcome measure(s) |
1. Compliance with supplements |
| Completion date | 24/01/2006 |
Eligibility
| Participant type(s) | Patient |
|---|---|
| Age group | Adult |
| Sex | Female |
| Target sample size at registration | 7144 |
| Total final enrolment | 5828 |
| Key inclusion criteria | Women invited to participate in the trial must be less than 28 weeks of gestation |
| Key exclusion criteria | Women will be excluded from the trial if already taking iron, folate, and other micronutrients supplements for more than two weeks |
| Date of first enrolment | 01/08/2002 |
| Date of final enrolment | 24/01/2006 |
Locations
Countries of recruitment
- China
Study participating centre
710061
China
Results and Publications
| Individual participant data (IPD) Intention to share | No |
|---|---|
| IPD sharing plan summary | |
| IPD sharing plan | Not provided at time of registration |
Study outputs
| Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
|---|---|---|---|---|---|
| Results article | results | 07/11/2008 | Yes | No | |
| Results article | results | 09/07/2009 | Yes | No | |
| Results article | 30-month follow-up results | 01/02/2012 | Yes | No | |
| Results article | results | 01/08/2015 | Yes | No | |
| Results article | results | 01/11/2016 | Yes | No | |
| Results article | results | 01/09/2018 | Yes | No | |
| Results article | results | 01/06/2020 | 12/08/2019 | Yes | No |
| Results article | 14-year follow-up | 07/12/2022 | 19/12/2022 | Yes | No |
| Participant information sheet | Participant information sheet | 11/11/2025 | 11/11/2025 | No | Yes |
Editorial Notes
19/12/2022: Publication reference added.
12/08/2019: Publication reference and total final enrolment added.
11/07/2018: Publication reference added.
28/07/2016: Publication reference added.